NLRP3 and chronic kidney disease: We have previously identified CD1c+ DC as a key myeloid cell source of IL-1β in human CKD, mediated via complex NLRP3 inflammasome-dependent interactions with damaged PTEC within the hypoxic tubulointerstitium [12].